Evidence map›Paper›PMID 23734165›Full record

ArticleDrug discovery today. Disease mechanisms2012

Catechol-

James D Yager

Open access · greenAbstract read
In one paragraph

Article in Drug discovery today. Disease mechanisms, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Advances in Membrane-Bound Catechol-International journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Analytical methodologies for sensing catechol-Journal of pharmaceutical analysis · 2021
    Review
  11. Catechol-O-Methyltransferase and Cardiovascular Disease: MESA.Journal of the American Heart Association · 2019
    Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Etiology and prevention of prevalent types of cancer.Journal of rare diseases research & treatment · 2017
    Article
  18. Genotoxicity ofToxicology research · 2017
    Article
  19. Catechol-O-methyltransferase association with hemoglobin A1c.Metabolism: clinical and experimental · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

James D YagerJohns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD 21205, United States.
Johns Hopkins University · US

Funding

PILOT STUDY--ACID FOG, AN EXPERIMENTAL MODELP30ES003819 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI GROOPMAN, JOHN D · 1985 to 2012
$22.6M
Traning Program in Environmental Health SciencesT32ES007141 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI Marsha Wills-Karp · 1985 to 2026
$22.2M
CATECHOL-O-METHYLTRANSFERASE AND BREAST CANCERR01CA077550 · NCI · JOHNS HOPKINS UNIVERSITY · PI YAGER, JAMES DONALD · 1998 to 2007
$1.7M
NCI NIH HHS R01 CA077550NIEHS NIH HHS P30 ES003819NIEHS NIH HHS T32 ES007141
6 · The paper itself

Abstract

Catechol estrogens are carcinogenic, probably because of their estrogenicity and potential for further oxidative metabolism to reactive quinones. Estrogenic quinones cause oxidative DNA damage as well as form mutagenic depurinating adenine and guanine adducts.

Identifiers

PMID23734165
PMCPMC3665426
OpenAlexW1980196112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.